BioCentury
ARTICLE | Company News

Raptor Pharmaceuticals Corp., Washington University deal

November 13, 2006 8:00 AM UTC

RPTP licensed exclusive worldwide rights to the university's proteins and peptides derived from the mesoderm development (Mesd) gene sequence for therapeutic use in cancer and bone diseases. The Mesd ...